NUCLEAR RECEPTORS FOR RETINOIDS - MEDIATORS OF RETINOID EFFECTS ON NORMAL AND MALIGNANT-CELLS

被引:58
|
作者
LOTAN, R
CLIFFORD, JL
机构
[1] Department of Tumor, The university of Texas MD Anderson Cancer Center, Houston
关键词
RETINOIDS; NUCLEAR RECEPTORS; GENE EXPRESSION;
D O I
10.1016/0753-3322(91)90102-Y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Retinoids are a group of natural and synthetic vitamin A analogues that Possess the unique ability to modulate the growth and differentiation of normal, premalignant and malignant epithelial and mesenchymal cells in vitro and in vivo. Naturally occurring retinoids act as physiologic regulators of embryonal development and maintain the proper differentiation of many epithelial tissues in the adult. Retinoids also act pharmacologically to restore regulation of differentiation and growth in certain premalignant and malignant cells in vitro and in vivo. Consequently, these compounds are being evaluated clinically for cancer prevention and therapy. There are strong indications that retinoids exert their diverse effects by regulating the expression of specific genes. The mechanism of this action is beginning to bc unraveled following the discovery that nuclear receptors for retinoic acid are present in many cells and tissues. These receptors belong to the large family comprising steroid, thyroid hormone, and vitamin D3 receptors, which are DNA-binding proteins that function as trans-acting transcription modulating factors. We review here some of the properties of these receptors, their interactions with responsive elements in the promoter region of specific genes, and the recent demonstration of their involvement as mediators of the effects of retinoids on growth and differentiation.
引用
收藏
页码:145 / 156
页数:12
相关论文
共 50 条
  • [1] Nuclear retinoid receptors: Mediators of retinoid effects
    vanderSaag, PT
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1996, 50 : S24 - S28
  • [2] EFFECTS OF RETINOIDS ON MALIGNANT-CELLS OF THE OSTEOBLAST LINEAGE
    OREFFO, ROC
    TRIFFITT, JT
    FRANCIS, MJO
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (05) : 947 - 948
  • [3] Differential expression of nuclear retinoid receptors in normal and malignant prostates
    Lotan, Y
    Xu, XC
    Shalev, M
    Lotan, R
    Williams, R
    Wheeler, TM
    Thompson, TC
    Kadmon, D
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) : 116 - 121
  • [4] EFFECTS OF 13-CIS RETINOIDS ON PREMALIGNANT AND MALIGNANT-CELLS OF LUNG ORIGIN
    SACCOMANNO, G
    MORAN, PG
    SCHMIDT, R
    HARTSHORN, DF
    BRIAN, DA
    DREHER, WH
    SOWADA, BJ
    ACTA CYTOLOGICA, 1982, 26 (01) : 78 - 85
  • [5] Links between pharmacological properties of retinoids and nuclear retinoid receptors
    Bollag, W
    Isnardi, L
    Jablonska, S
    Klaus, M
    Majewski, S
    Pirson, W
    Toma, S
    INTERNATIONAL JOURNAL OF CANCER, 1997, 70 (04) : 470 - 472
  • [6] DIFFERENTIATION TRAJECTORIES IN NORMAL AND MALIGNANT-CELLS
    MATIOLI, GT
    MEDICAL HYPOTHESES, 1990, 31 (01) : 71 - 80
  • [7] EXPRESSION OF INTEGRIN CELL-SUBSTRATUM ADHESION RECEPTORS BY NORMAL AND MALIGNANT-CELLS
    ALBELDA, SM
    METTE, SA
    BUCK, CA
    CLINICAL RESEARCH, 1989, 37 (02): : A472 - A472
  • [8] CONVERSION OF MALIGNANT-CELLS INTO NORMAL ONES
    SHVEMBERGER, IN
    INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY, 1986, 103 : 341 - 386
  • [9] ALPHA-FETOPROTEIN RECEPTORS IN MALIGNANT-CELLS
    URIEL, J
    GEUSKENS, M
    NAVAL, J
    VILLACAMPA, MJ
    TUMOUR BIOLOGY, 1985, 6 (04): : 308 - 308
  • [10] DIFFERENTIAL EXPRESSION OF NUCLEAR RETINOID RECEPTORS IN NORMAL, PREMALIGNANT, AND MALIGNANT HEAD AND NECK TISSUES
    XU, XC
    RO, JY
    LEE, JS
    SHIN, DM
    HONG, WK
    LOTAN, R
    CANCER RESEARCH, 1994, 54 (13) : 3580 - 3587